| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | CA2396372A1 Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
| 08/02/2001 | CA2395730A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | CA2395447A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 08/02/2001 | CA2395446A1 Compositions, kits, and methods for cardiovascular health |
| 08/02/2001 | CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/01/2001 | EP1120117A1 Method of increasing the production of eggs and strengthening eggshells in poultry |
| 08/01/2001 | EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119571A2 Tricyclic delta3-piperidines as alpha2-antagonists |
| 08/01/2001 | EP1119570A1 Tricyclic delta3-piperidines as pharmaceuticals |
| 08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/01/2001 | EP1119567A1 Quinazoline derivatives |
| 08/01/2001 | EP1119557A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 08/01/2001 | EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 08/01/2001 | EP1119543A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 08/01/2001 | EP1119368A2 Methods of modulating lipid metabolism and storage |
| 08/01/2001 | EP1119363A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 08/01/2001 | EP1119362A1 Method of using tetracycline compounds to enhance interleukin-10 production |
| 08/01/2001 | EP1119353A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
| 08/01/2001 | CN1306580A Mumbaistatin, process for its prodn. and its use as pharmaceutical |
| 08/01/2001 | CN1306568A Human bile salt-stimulated lipase (BSSL) obtainable from transgenic sheep |
| 08/01/2001 | CN1306541A Compound for unstable dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306540A Prodrugs of dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306530A Paroxetine 10-camphorsulfonate for treament of CNS disorders |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306511A Novel heterocyclic compounds |
| 08/01/2001 | CN1306433A Use of chemically-stabilized chlorite solution for inhibiting antigen-specific immune response |
| 08/01/2001 | CN1306431A Compsns. for increasing energy i(in vivo) |
| 08/01/2001 | CN1305832A Special health-care product for juvenile and its preparing process |
| 08/01/2001 | CN1305829A Process for preparing medicine (Sanpigualou powder) to treat diabetes |
| 08/01/2001 | CN1305817A Hypolipemic instant powder |
| 08/01/2001 | CN1305816A Medicine for treating diabetes |
| 08/01/2001 | CN1305815A Hypoglycemic, antihypertensive and antisenility powder for dietotherapy and its preparing process |
| 08/01/2001 | CN1305805A Compsns. contg. ascorbic acid and pectin |
| 08/01/2001 | CN1069050C Compounded Chinese medicine for treating diabetes |
| 07/31/2001 | US6268398 Aromatic guanidine derivatives |
| 07/31/2001 | US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
| 07/31/2001 | US6268382 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 07/31/2001 | US6268369 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 07/31/2001 | US6268365 Src family SH2 domain inhibitors |
| 07/31/2001 | US6268364 Substitued tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents |
| 07/31/2001 | US6268343 Derivatives of GLP-1 analogs |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268335 Insoluble insulin compositions |
| 07/31/2001 | US6268186 By recovering compounds such as lovastatin from a fermentation broth by purifying with an adsorbent resin, extraction using toluene, lactonization, if necessary and washing in toluene with water before isolation |
| 07/31/2001 | US6268182 Enzymatically degrading starch in combination with glycosyltransferase to act on starch having at least one phosphate group per molecule; phosphorylated saccharide reacts with minerals and prevents insolubization of minerals |
| 07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
| 07/31/2001 | US6268011 Mixture of soybean protein and soybean fiber |
| 07/31/2001 | US6267992 Administering metabolite of salviae miltiorrhizac radix herb to diabetic individual to treat diabetic nephropathy |
| 07/31/2001 | US6267988 Composition and method for inducing satiety |
| 07/31/2001 | US6267952 Lipase inhibiting polymers |
| 07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2072945C Pyrimidine derivatives |
| 07/26/2001 | WO2001053540A1 Antisense modulation of pepck-cytosolic expression |
| 07/26/2001 | WO2001053528A1 Antisense inhibition of ptp1b expression |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053353A2 Recombinant antibodies to human interkleukin-1 beta |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053311A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 07/26/2001 | WO2001053295A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 07/26/2001 | WO2001053291A1 Benzimidazole derivatives |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | WO2001053278A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 07/26/2001 | WO2001053272A1 Human chymase inhibitors |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001053260A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 07/26/2001 | WO2001053257A2 Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053256A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052937A1 Mixed buffer system for stabilizing polypeptide formulations |
| 07/26/2001 | WO2001052903A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | WO2001052902A1 Antisense modulation of inducible nitric oxide synthase expression |
| 07/26/2001 | WO2001052880A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | WO2001052878A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 07/26/2001 | WO2001052876A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | WO2001052871A1 Preparation and xenotransplantation of porcine islets |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052862A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | WO2001052860A2 Method and composition for modulating an immune response |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052849A1 Remedies for diabetes |
| 07/26/2001 | WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | WO2001052829A2 Statin-type bone growth stimulators |
| 07/26/2001 | WO2001052825A2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/26/2001 | WO2001052817A2 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000047238A9 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 07/26/2001 | US20010009923 Salt with pamoic acid, used in treatment of myocardial ischemia, angina pectoris, heart failure and arrhythmias; muscular asthenia and cramps; as food supplement, dietetic |
| 07/26/2001 | US20010009920 Combination therapy for osteoporosis |